retatrutide clinical trial results weight loss retatrutide Lilly's triple agonist achieves 16.8% in phase 3 New GLP-1 obesity drug, retatrutide,
Pay in 4 interest-free payments of $7.47 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26


























